Competition between inside-out unfolding and pathogenic aggregation in an amyloid-forming β-propeller. 2024

Emily G Saccuzzo, and Mubark D Mebrat, and Hailee F Scelsi, and Minjoo Kim, and Minh Thu Ma, and Xinya Su, and Shannon E Hill, and Elisa Rheaume, and Renhao Li, and Matthew P Torres, and James C Gumbart, and Wade D Van Horn, and Raquel L Lieberman
School of Chemistry & Biochemistry, Georgia Institute of Technology, Atlanta, USA.

Studies of folded-to-misfolded transitions using model protein systems reveal a range of unfolding needed for exposure of amyloid-prone regions for subsequent fibrillization. Here, we probe the relationship between unfolding and aggregation for glaucoma-associated myocilin. Mutations within the olfactomedin domain of myocilin (OLF) cause a gain-of-function, namely cytotoxic intracellular aggregation, which hastens disease progression. Aggregation by wild-type OLF (OLFWT) competes with its chemical unfolding, but only below the threshold where OLF loses tertiary structure. Representative moderate (OLFD380A) and severe (OLFI499F) disease variants aggregate differently, with rates comparable to OLFWT in initial stages of unfolding, and variants adopt distinct partially folded structures seen along the OLFWT urea-unfolding pathway. Whether initiated with mutation or chemical perturbation, unfolding propagates outward to the propeller surface. In sum, for this large protein prone to amyloid formation, the requirement for a conformational change to promote amyloid fibrillization leads to direct competition between unfolding and aggregation.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D005901 Glaucoma An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed) Glaucomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000682 Amyloid A fibrous protein complex that consists of proteins folded into a specific cross beta-pleated sheet structure. This fibrillar structure has been found as an alternative folding pattern for a variety of functional proteins. Deposits of amyloid in the form of AMYLOID PLAQUES are associated with a variety of degenerative diseases. The amyloid structure has also been found in a number of functional proteins that are unrelated to disease. Amyloid Fibril,Amyloid Fibrils,Amyloid Substance,Fibril, Amyloid,Fibrils, Amyloid,Substance, Amyloid
D016229 Amyloid beta-Peptides Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. Alzheimer beta-Protein,Amyloid Protein A4,Amyloid beta-Peptide,Amyloid beta-Protein,beta Amyloid,beta-Amyloid Protein,Alzheimer's ABP,Alzheimer's Amyloid Fibril Protein,Amyloid AD-AP,Amyloid Fibril Protein, Alzheimer's,Amyloid beta-Proteins,ABP, Alzheimer's,AD-AP, Amyloid,Alzheimer ABP,Alzheimer beta Protein,Alzheimers ABP,Amyloid AD AP,Amyloid beta Peptide,Amyloid beta Peptides,Amyloid beta Protein,Amyloid beta Proteins,Amyloid, beta,Protein A4, Amyloid,Protein, beta-Amyloid,beta Amyloid Protein,beta-Peptide, Amyloid,beta-Peptides, Amyloid,beta-Protein, Alzheimer,beta-Protein, Amyloid,beta-Proteins, Amyloid
D017510 Protein Folding Processes involved in the formation of TERTIARY PROTEIN STRUCTURE. Protein Folding, Globular,Folding, Globular Protein,Folding, Protein,Foldings, Globular Protein,Foldings, Protein,Globular Protein Folding,Globular Protein Foldings,Protein Foldings,Protein Foldings, Globular
D058227 Amyloidogenic Proteins Proteins that form the core of amyloid fibrils. For example, the core of amyloid A is formed from amyloid A protein, also known as serum amyloid A protein or SAA protein. Amyloid Protein,Amyloidogenic Protein,Amyloid Proteins,Protein, Amyloid,Protein, Amyloidogenic,Proteins, Amyloid,Proteins, Amyloidogenic

Related Publications

Emily G Saccuzzo, and Mubark D Mebrat, and Hailee F Scelsi, and Minjoo Kim, and Minh Thu Ma, and Xinya Su, and Shannon E Hill, and Elisa Rheaume, and Renhao Li, and Matthew P Torres, and James C Gumbart, and Wade D Van Horn, and Raquel L Lieberman
June 2009, Journal of molecular biology,
Emily G Saccuzzo, and Mubark D Mebrat, and Hailee F Scelsi, and Minjoo Kim, and Minh Thu Ma, and Xinya Su, and Shannon E Hill, and Elisa Rheaume, and Renhao Li, and Matthew P Torres, and James C Gumbart, and Wade D Van Horn, and Raquel L Lieberman
May 2020, The Journal of biological chemistry,
Emily G Saccuzzo, and Mubark D Mebrat, and Hailee F Scelsi, and Minjoo Kim, and Minh Thu Ma, and Xinya Su, and Shannon E Hill, and Elisa Rheaume, and Renhao Li, and Matthew P Torres, and James C Gumbart, and Wade D Van Horn, and Raquel L Lieberman
August 2019, Aging and disease,
Emily G Saccuzzo, and Mubark D Mebrat, and Hailee F Scelsi, and Minjoo Kim, and Minh Thu Ma, and Xinya Su, and Shannon E Hill, and Elisa Rheaume, and Renhao Li, and Matthew P Torres, and James C Gumbart, and Wade D Van Horn, and Raquel L Lieberman
February 2009, Journal of molecular biology,
Emily G Saccuzzo, and Mubark D Mebrat, and Hailee F Scelsi, and Minjoo Kim, and Minh Thu Ma, and Xinya Su, and Shannon E Hill, and Elisa Rheaume, and Renhao Li, and Matthew P Torres, and James C Gumbart, and Wade D Van Horn, and Raquel L Lieberman
November 2018, Nature,
Emily G Saccuzzo, and Mubark D Mebrat, and Hailee F Scelsi, and Minjoo Kim, and Minh Thu Ma, and Xinya Su, and Shannon E Hill, and Elisa Rheaume, and Renhao Li, and Matthew P Torres, and James C Gumbart, and Wade D Van Horn, and Raquel L Lieberman
May 2012, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques,
Emily G Saccuzzo, and Mubark D Mebrat, and Hailee F Scelsi, and Minjoo Kim, and Minh Thu Ma, and Xinya Su, and Shannon E Hill, and Elisa Rheaume, and Renhao Li, and Matthew P Torres, and James C Gumbart, and Wade D Van Horn, and Raquel L Lieberman
May 2018, ACS omega,
Emily G Saccuzzo, and Mubark D Mebrat, and Hailee F Scelsi, and Minjoo Kim, and Minh Thu Ma, and Xinya Su, and Shannon E Hill, and Elisa Rheaume, and Renhao Li, and Matthew P Torres, and James C Gumbart, and Wade D Van Horn, and Raquel L Lieberman
July 2020, RSC advances,
Emily G Saccuzzo, and Mubark D Mebrat, and Hailee F Scelsi, and Minjoo Kim, and Minh Thu Ma, and Xinya Su, and Shannon E Hill, and Elisa Rheaume, and Renhao Li, and Matthew P Torres, and James C Gumbart, and Wade D Van Horn, and Raquel L Lieberman
November 2017, Biochemical and biophysical research communications,
Emily G Saccuzzo, and Mubark D Mebrat, and Hailee F Scelsi, and Minjoo Kim, and Minh Thu Ma, and Xinya Su, and Shannon E Hill, and Elisa Rheaume, and Renhao Li, and Matthew P Torres, and James C Gumbart, and Wade D Van Horn, and Raquel L Lieberman
July 2016, Physical chemistry chemical physics : PCCP,
Copied contents to your clipboard!